Status:
UNKNOWN
Outcome of Patients Treated With ECLS
Lead Sponsor:
Nanjing Medical University
Conditions:
Cardiogenic Shock
Cardiac Arrest
Eligibility:
All Genders
1-100 years
Brief Summary
Extracorporeal life support (ECLS), also called extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective circulatory and (or) respiratory failure, with a growi...
Eligibility Criteria
Inclusion
- Patients receiving ECMO for circulatory and/or respiratory support
Exclusion
- Refusal of consent
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04405817
Start Date
January 1 2012
End Date
December 31 2025
Last Update
May 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The first affiliated hospital of nanjing medical university
Nanjing, Jiangsu, China, 210029